Home / Sweden / RaySearch Laboratories AB (publ)
RaySearch Laboratories AB (publ)
Short position disclosed on September 14, 2026.
Evolution of the disclosed total
August 20, 2017 today
Open positions
| Fund | Twelve months | % of capital | Over the year | Since |
|---|---|---|---|---|
| JPMorgan Asset Management (UK) Ltd | 1.08% | new | July 17, 2026 | |
| GSA Capital Partners LLP | 1.00% | new | September 14, 2026 | |
| Connor Clark & Lunn Investment Management Ltd. | 0.99% | new | August 17, 2026 | |
| D E Shaw Co LP | 0.68% | new | July 31, 2026 | |
| Tudor Capital Europe LLP | 0.61% | new | September 7, 2026 |
In the United States RSLBF (OTC): 219,825 shares sold short on August 31, 2026. FINRA names no fund.
On the other side: the funds that hold RaySearch Laboratories AB (publ) Titelia
Get the moves on RaySearch Laboratories AB (publ) by mail.
No account: one address, one link to confirm, one link to stop in every message.
History of disclosures
Download 216 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats
Other companies sold short in Sweden
- Samhällsbyggnadsbolaget i Norden AB 11.99% of the capital sold short
- Elekta AB (publ) 9.12% of the capital sold short
- JM AB 7.52% of the capital sold short
- Bonesupport Holding AB 6.69% of the capital sold short
- Truecaller AB 6.51% of the capital sold short
- Hemnet Group AB (publ) 6.13% of the capital sold short
- Xvivo Perfusion Aktiebolag 5.41% of the capital sold short
- Dynavox Group AB 4.57% of the capital sold short
- Aktiebolaget Electrolux 4.32% of the capital sold short
- AAK AB (publ) 4.23% of the capital sold short
- Mips AB 3.82% of the capital sold short
- Tobii AB 3.54% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, RaySearch Laboratories AB (publ), source Finansinspektionen, data as at September 14, 2026, https://www.quivad.com/action/raysearch-laboratories-ab-publ